ADMP

Q: What is the price of Adamis Pharmaceuticals (ADMP) today?

The current price of Adamis Pharmaceuticals (ADMP) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Adamis Pharmaceuticals (ADMP) pay dividends?

Adamis Pharmaceuticals (ADMP) did not pay dividends over the past year.

Adamis Pharmaceuticals Corporation

Price

return (12m)

0.00%

p/e

-0.07

p/bv

0.00

DIVIDEND YIELD

0.00%

ADMP price

Adamis Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ADMP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ADMP

review the fundamentals of Adamis Pharmaceuticals shares

P/E

-0.07

Sector: -1.71 Industry: -5.36

P/S (PSR)

0.25

Sector: 1.98 Industry: 3.01

P/BV

0.00

Sector: 2.11 Industry: 1.89

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-0.54%

Sector: -28.05% Industry: -49.70%

ROE

0.97%

Sector: -33.97% Industry: -46.83%

ROIC

Sector: -441.74% Industry: -539.51%

NET MARGIN

-100.00%

Sector: -29.81% Industry: -37.22%

GROSS MARGIN

54.05%

Sector: 45.08% Industry: 48.78%

OPERATING MARGIN

-100.00%

Sector: -24.71% Industry: -32.90%

EV/EBITDA

-0.12

Sector: -0.10 Industry: -3.02

EV/EBIT

-0.12

Sector: -1.70 Industry: -5.08

PRICE-TO-ASSETS

0.00

Sector: 1.17 Industry: 1.26

BVPS

-702.64

Sector: 3.83 Industry: 2.08

EPS

-6.82

Sector: -0.90 Industry: -1.29

EQUITY-TO-ASSETS RATIO

-0.55

Sector: 0.43 Industry: 0.49

LIABILITIES / ASSETS

-0.55

Sector: 0.46 Industry: 0.43

CAGR REVENUE 5 YEARS

6.93%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

3.25%

Sector: - Industry: -

Fundamentals ADMP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.12	32.50	81.02%	0.57%	$1.01 T	34.99%
ISRG	48.98	8.29	16.93%	0.00%	$145.93 B	28.15%
SNY	7.23	1.29	17.79%	3.99%	$108.01 B	14.75%
TMO	25.50	3.35	13.15%	0.38%	$174.59 B	15.15%
NVS	21.59	7.51	34.77%	2.03%	$292.21 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$149.12 B	13.91%
MDT	21.42	0.00	-%	3.54%	$102.82 B	13.20%
GSK	13.49	4.56	33.77%	3.33%	$105.82 B	17.79%
CVS	44.27	1.67	3.78%	2.61%	$129.80 B	0.72%
BSX	19.67	2.71	13.78%	0.00%	$70.13 B	17.29%
TMDX	14.42	5.02	34.80%	0.00%	$2.48 B	27.04%
IDXX	40.97	28.84	70.38%	0.00%	$44.87 B	24.63%
HCA	12.77	-29.12	-228.14%	0.76%	$86.73 B	8.89%
RMD	18.53	4.34	23.41%	0.93%	$28.16 B	27.44%
DHR	34.57	2.41	6.97%	0.76%	$127.51 B	14.89%
INMD	9.72	1.28	13.18%	0.00%	$847.35 M	23.27%
PHG	22.29	1.91	8.56%	3.83%	$25.19 B	5.50%
SYK	35.73	5.19	14.52%	1.11%	$119.24 B	13.21%
CI	12.12	1.87	15.39%	2.04%	$78.74 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ADMP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation

Average Investor10 user rating

4.0 (1 people)

United States

22 years

Founded: 2004

1995

Time since IPO - 31 years

143

Employees

Adamis Pharmaceuticals Corporation (United States) is listed on the Nasdaq and has a market capitalization of $3.46 million, with shareholders equity totaling $-4.96 billion.

The company employs approximately 143 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Adamis Pharmaceuticals Corporation reported $13.77 million in revenue, generating net income of $-48.17 million.

Key financial metrics include a P/E ratio of -0.07, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ADMP.

Market cap

$3.46 million

Net worth

$-4.96 billion

$-4,964,639,000.00

Assets

$8.96 billion

$8,957,411,000.00

Total Shares Outstanding

7.07 million

7,065,000

Average Daily Trading Volume

$1.51 million

$1,507,479.60

Sector

Health

Industry

Pharmaceutical Products

ADMP

ADMP revenue and profits

Financial Results ADMP

DRAG THE FRAME TO SEE MORE DATA

ADMP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$98.32 53,08% (12M)

P/E

44.27

2.61%

ROE

3.78%

P/BV

1.67

CI - Cigna

$279.27 --9,20% (12M)

P/E

12.12

2.04%

ROE

15.39%

P/BV

1.87

CNC - Centene

$61.02 12,17% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$360.65 53,24% (12M)

P/E

40.27

0.93%

ROE

6.06%

P/BV

2.44

SNY - Sanofi

$42.38 --7,96% (12M)

P/E

7.23

3.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$1,098.57 43,57% (12M)

P/E

40.12

0.57%

ROE

81.02%

P/BV

32.50

HCA - HCA Healthcare

$375.17 0,23% (12M)

P/E

12.77

0.76%

ROE

-228.14%

P/BV

-29.12

NVS - Novartis

$147.09 29,52% (12M)

P/E

21.59

2.03%

ROE

34.77%

P/BV

7.51

CVS - CVS Health

$98.32 53,08% (12 M)

P/L

44.27

2.61%

ROE

3.78%

P/VP

1.67

CI - Cigna

$279.27 --9,20% (12 M)

P/L

12.12

2.04%

ROE

15.39%

P/VP

1.87

CNC - Centene

$61.02 12,17% (12 M)

P/L

-4.98

0.00%

ROE

-29.93%

P/VP

1.49

HUM - Humana

$360.65 53,24% (12 M)

P/L

40.27

0.93%

ROE

6.06%

P/VP

2.44

SNY - Sanofi

$42.38 --7,96% (12 M)

P/L

7.23

3.99%

ROE

17.79%

P/VP

1.29

LLY - Eli Lilly

$1,098.57 43,57% (12 M)

P/L

40.12

0.57%

ROE

81.02%

P/VP

32.50

HCA - HCA Healthcare

$375.17 0,23% (12 M)

P/L

12.77

0.76%

ROE

-228.14%

P/VP

-29.12

NVS - Novartis

$147.09 29,52% (12 M)

P/L

21.59

2.03%

ROE

34.77%

P/VP

7.51

Frequently Asked Questions

What is the price of Adamis Pharmaceuticals (ADMP) today?

The current price of Adamis Pharmaceuticals (ADMP) is $0.00. The stock began the year trading around $0.00 and is currently priced at $0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Adamis Pharmaceuticals (ADMP) pay dividends?

Adamis Pharmaceuticals (ADMP) did not pay dividends over the past year.

Is Adamis Pharmaceuticals (ADMP) a good investment?

Adamis Pharmaceuticals (ADMP) is currently trading at $0.00 with a P/E ratio of -0.07. This represents a -1,967% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Adamis Pharmaceuticals (ADMP) stock?

You can buy Adamis Pharmaceuticals (ADMP) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ADMP and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Adamis Pharmaceuticals (ADMP) yield today?

Over the past month, Adamis Pharmaceuticals (ADMP) has returned 0.00% — 0.00% over the past year, and 0.00% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Adamis Pharmaceuticals (ADMP) today at the current price of $0.00 your total investment would be $0.00.

Based on historical performance, the investment would have grown to approximately:

$0.00 after 1 year
$0.00 after 5 years
$0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ADMP

Adamis Pharmaceuticals Corporation

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ADMP

review the fundamentals of Adamis Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Adamis Pharmaceuticals

Adamis Pharmaceuticals Corporation

United States

22 years

1995

143

PROFIT X PRICE ADMP

Financial Results ADMP

ADMP cash flow

Asset, Revenue and Profit Growth - ADMP

ADMP balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions